MN
Michael Paul North
Chief Information Officer

Michael Paul North insider trades: Amedisys (AMED) stock sales

Chief Information Officer, Amedisys Last trade Mar 3, 2023 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2018
1
Company
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 3, 2023AMED↓ Sell$511K
Apr 27, 2021AMED↓ Sell$502K
Sep 9, 2020AMED↓ Sell$936K
Feb 21, 2020AMED↓ Sell$1.8M
Jul 24, 2019AMED↓ Sell$1.3M
Jul 18, 2019AMED↓ Sell$154K
Jun 5, 2019AMED↓ Sell$604K
Dec 12, 2018AMED↓ Sell$1.0M
Nov 15, 2018AMED↓ Sell$707K
Nov 14, 2018AMED↓ Sell$661K
May 11, 2018AMED↓ Sell$787K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael Paul North's insider trades

Michael Paul North is Chief Information Officer at Amedisys (AMED). Since May 11, 2018, Michael has reported no open-market purchases and 11 sales worth $9.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include shares withheld for taxes (14 filings), option exercises (10 filings), grants and awards (9 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.